Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions

This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study will evaluate the performance and safety of OROSEDAL in children and adults with sore throat or minor oral lesions, including minor aphthous ulcers and histologically confirmed oral lichen planus. OROSEDAL is prescribed in routine practice before inclusion. Patients will be followed for 6 ± 1 days and will complete self-assessments of pain, swallowing discomfort, treatment use, and adverse events.

NCT Number	NCT07620353
Lead Sponsor	Laboratoires Elerte Collaborators: Clin-Experts
Conditions	Sore Throat, Aphthous Ulcer, Oral Lichen Planus, Minor Mouth Lesion, Oral Pain
Enrollment	124 participants
Start Date	2026-03-05
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-02